|Study Name||Who's Treated?||Age||Treatment components||Duration||Study Status|
|Quetiapine for Marijuana Dependence||Marijuana users||18-60||Quetiapine (Seroquel®) or placebo (double-blind)
Individual sessions of medical management therapy weekly
|12 week outpatient medication trial requiring 2 clinic visits per week||Active and recruiting participants|
Quetiapine Pharmacotherapy for Cannabis Dependence
The purpose of this research study is to evaluate the efficacy of quetiapine for the treatment of marijuana dependence. Quetiapine is not currently approved by the FDA for this purpose and has not been studied for marijuana dependence. It is FDA-approved for bipolar disorder and schizophrenia.
Type of Treatment:
This study involves 12 weeks of outpatient medication treatment requiring clinic visits twice a week. At each clinic visit vital signs will be checked, questionnaires completed and a urine sample collected. Once per week, in a 30-minute session the psychiatrist will perform study evaluations and work on treatment goals.Medication will be dispensed once per week during a study visit to be taken at home daily.After the study is finished, patients are able to continue meeting with psychiatrist for 4 weeks. This is to go over progress made during the trial and to find referrals for continued treatment if requested.
Cutting edge approaches to treating addiction to marijuana, benzodiazepines, cocaine, heroin or narcotic painkillers are available in a supportive and professional environment.